Fredun Pharmaceuticals Ltd posts Rs. 32.83 lakhs PAT in Q1FY22

Fredun Pharmaceuticals Limited has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.45.24 crores during the period ended June 30, 2021 as compared to Rs.42.37 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.3283 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.7271 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.82 for the period ended June 30, 2021 as compared to Rs.1.82 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 45.24 crs	₹ 42.37 crs	6.77%
Net Profit	₹ 0.3283 crs	₹ 0.7271 crs	-54.85%
EPS	₹ 0.82	₹ 1.82	-54.95%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.45.24 crores during the period ended June 30, 2021 as compared to Rs.13.74 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.0.3283 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.0362 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.0.82 for the period ended June 30, 2021 as compared to Rs.0.09 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 45.24 crs	₹ 13.74 crs	229.26%
Net Profit	₹ 0.3283 crs	₹ 0.0362 crs	806.91%
EPS	₹ 0.82	₹ 0.09	811.11%

Shares of Fredun Pharmaceuticals Limited was last trading in BSE at Rs. 439 as compared to the previous close of Rs. 428.65. The total number of shares traded during the day was 3017 in over 88 trades.

The stock hit an intraday high of Rs. 449.95 and intraday low of 432.25. The net turnover during the day was Rs. 1322292.

Source : Equity Bulls

Keywords